You just read:

FDA Approves FENSOLVI® (leuprolide acetate) for Injectable Suspension for Pediatric Patients with Central Precocious Puberty

News provided by

Tolmar Pharmaceuticals, Inc.

May 04, 2020, 06:05 ET